KML29
CAS No. : 1380424-42-9
| Size | Price | Stock |
|---|---|---|
| 5mg | $50 | In-stock |
| 10mg | $82 | In-stock |
| 25mg | $173 | In-stock |
| 50mg | $260 | In-stock |
| 100mg | $390 | In-stock |
| 200 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-18977 |
| M.Wt: | 549.42 |
| Formula: | C24H21F6NO7 |
| Purity: | >98 % |
| Solubility: | DMSO : 50 mg/mL (ultrasonic) |
KML29 is an extremely selective, orally active and irreversible MAGL inhibitor, with IC50 values of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively. KML29 exhibits minimal cross-reactivity toward other central and peripheral serine hydrolases, including no detectable activity against FAAH[1][2].
IC50 & Target:IC50: 15 nM (mouse MAGL), 43 nM (rat MAGL), 5.9 nM (human MAGL)[2].
In Vitro: KML29 dose-dependently elevates brain 2-AG level up to 10-fold without alteration in brain levels of anandamide, palmitoylethanolamide, and oleoylethanolamide[2].
KML29 is a potent inhibitor of 2-AG hydrolysis, but did not affect AEA hydrolysis at any concentration tested[2].
In Vivo: KML29 enhibits antinociceptive activity without cannabimimetic side effects[3].
KML29 (20 mg/kg) has a significant but modest protective effect against LPS-induced fever[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- KML29
- Cat. No.:
- HY-18977
- Quantity:
Your information is safe with us.